@prefix dc1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAQlGtCS1HeeDh6g0zpiuPbS9VXw3zxNeVdThVdAH8NPc> .
@prefix sub: <http://purl.org/np/RAQlGtCS1HeeDh6g0zpiuPbS9VXw3zxNeVdThVdAH8NPc#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_11168> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_11168>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB01179>;
    a rdf:Statement;
    rdfs:label "condylox gel 5 is indicated for the topical treatment of anogenital warts external genital warts and perianal warts this product is not precautions although anogenital warts have a characteristic appearance histopathologic confirmation should be obtained if there is any doubt of the diagnosis differentiating warts from squamous cell carcinoma and bowenoid papulosis is of particular concern squamous cell carcinoma may also be associated with human papillomavirus which should not be treated with condylox gel 5";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB01179> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "MUtA+G7bgbjvb5UdS5pT4mjIg73IFmjqvrqcfctGgtndC0DZX9elEYGuVO5WToVUYrhzoDdzNjl1ZMJdjqueQo8doM6MXhSFxU/yHyRKQ8obE6QJTn34gmui4N7gk/hxQG0T3g0bixv7ynHKnhFzW9kgkOny/YbYKMycJrG6Dsg=";
    npx:hasSignatureTarget this: .
  
  this: dc1:created "2021-06-13T14:26:06.303+02:00"^^xsd:dateTime;
    dc1:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}